Trinity Biotech plc reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2009. For the quarter, the company reported operating profit of $3,731,000, profit before tax of $3,442,000, profit of $3,057,000, or 14.5 cents per diluted ADR on revenues of $31,705,000 compared to operating profit of $2,014,000, profit before tax of $1,552,000, profit of $1,321,000, or 6.3 cents per diluted ADR on revenues of $35,582,000 for the same period last year. The company reported cash generated from operations of $4,117,000, capital expenditure (Net) of $1,600,000 compared to cash generated from operations of $2,089,000, capital expenditure (Net) of $3,176,000 for the same period last year. For the nine months, the company reported operating profit of $10,614,000, profit before tax of $9,689,000, profit of $8,566,000, or 41.0 cents per diluted ADR on revenues of $95,113,000 compared to operating profit of $6,106,000, profit before tax of $4,455,000, profit of $3,879,000, or 19.2 cents per diluted ADR on revenues of $106,130,000 for the same period last year.

Trinity Biotech plc, Q3 2009 Earnings Call, Oct 21 2009

Trinity Biotech plc expected to Report Fiscal Year 2009 Results on March 1, 2010. This event was calculated by Capital IQ (Created on August 3, 2009).